Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVHI
2426
DELISTED
A V Homes, Inc.
AVHI
| $1.38M | ﹤0.01% |
121,000
-6,100
| -5% | -$64.5K |
|
2427
Rigel Pharmaceuticals
RIGL
$786M
| $1.37M | ﹤0.01% |
66,080
+16,120
| +32% | +$398K |
|
|
ATTU
2428
DELISTED
Attunity Ltd
ATTU
| $1.37M | ﹤0.01% |
191,915
-33,918
| -15% | -$269K |
|
|
IO
2429
DELISTED
ION Geophysical Corporation
IO
| $1.37M | ﹤0.01% |
169,782
-4,385
| -3% | -$25.5K |
|
2430
Asure Software
ASUR
$248M
| $1.37M | ﹤0.01% |
255,476
+1,600
| +0.6% | +$8.48K |
|
|
CRR
2431
DELISTED
Carbo Ceramics Inc.
CRR
| $1.37M | ﹤0.01% |
96,200
-160,800
| -63% | -$2.78M |
|
2432
Sterling Infrastructure
STRL
$17.5B
| $1.36M | ﹤0.01% |
264,000
+75,700
| +40% | +$381K |
|
2433
Ark Restaurants
ARKR
$20.2M
| $1.35M | ﹤0.01% |
65,600
+5,600
| +9% | +$119K |
|
2434
Olin
OLN
$2.16B
| $1.35M | ﹤0.01% |
+77,700
| New | +$1.2M |
|
|
AIMC
2435
DELISTED
Altra Industrial Motion Corp
AIMC
| $1.35M | ﹤0.01% |
+48,579
| New | +$1.16M |
|
2436
Fox Factory Holding Corp
FOXF
$885M
| $1.35M | ﹤0.01% |
85,300
+56,445
| +196% | +$867K |
|
2437
Distribution Solutions Group
DSGR
$1.61B
| $1.34M | ﹤0.01% |
137,400
-35,600
| -21% | -$338K |
|
|
DCP
2438
DELISTED
DCP Midstream, LP
DCP
| $1.34M | ﹤0.01% |
+49,410
| New | +$1.04M |
|
|
JNP
2439
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.34M | ﹤0.01% |
202,900
+15,300
| +8% | +$113K |
|
|
OREX
2440
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.34M | ﹤0.01% |
238,110
+61,490
| +35% | +$799K |
|
2441
Copa Holdings
CPA
$6.15B
| $1.33M | ﹤0.01% |
+19,700
| New | +$1.11M |
|
|
MOCO
2442
DELISTED
Mocon Inc
MOCO
| $1.33M | ﹤0.01% |
96,400
+6,200
| +7% | +$84.5K |
|
2443
StoneX
SNEX
$8.02B
| $1.33M | ﹤0.01% |
+252,097
| New | +$1.36M |
|
|
ITI
2444
DELISTED
Iteris, Inc.
ITI
| $1.33M | ﹤0.01% |
544,200
+23,700
| +5% | +$56.4K |
|
|
CIO
2445
DELISTED
City Office REIT
CIO
| $1.33M | ﹤0.01% |
116,412
+36,212
| +45% | +$429K |
|
2446
Geron
GERN
$930M
| $1.32M | ﹤0.01% |
+453,480
| New | +$1.36M |
|
|
UAM
2447
DELISTED
Universal American Corp
UAM
| $1.32M | ﹤0.01% |
185,300
+6,900
| +4% | +$44.8K |
|
2448
Aviat Networks
AVNW
$285M
| $1.31M | ﹤0.01% |
308,717
+23,900
| +8% | +$97.7K |
|
|
GUID
2449
DELISTED
Guidance Software, Inc.
GUID
| $1.31M | ﹤0.01% |
305,900
+32,100
| +12% | +$155K |
|
2450
Camtek
CAMT
$7.54B
| $1.31M | ﹤0.01% |
663,200
+50,600
| +8% | +$97.1K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.